[1]牟 婷,张朝阳.胰岛素联合唑来膦酸治疗糖尿病骨质疏松症对患者血清指标的影响[J].医学信息,2019,32(22):135-136.[doi:10.3969/j.issn.1006-1959.2019.22.045]
　MU Ting,ZHANG Chao-yang.Effect of Insulin Combined with Zoledronic Acid on Serum Markers in Patients with Diabetic Osteoporosis[J].Journal of Medical Information,2019,32(22):135-136.[doi:10.3969/j.issn.1006-1959.2019.22.045]
点击复制

胰岛素联合唑来膦酸治疗糖尿病骨质疏松症对患者血清指标的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
135-136
栏目:
药物与临床
出版日期:
2019-11-15

文章信息/Info

Title:
Effect of Insulin Combined with Zoledronic Acid on Serum Markers in Patients with Diabetic Osteoporosis
文章编号:
1006-1959（2019）22-0135-02
作者:
牟 婷1; 张朝阳2
（天津市宝坻区人民医院内分泌科1，骨科2，天津 301800）
Author(s):
MU Ting1; ZHANG Chao-yang2
(Department of Endocrinology1,Department of Orthopaedics2,People's Hospital of Baodi District,Tianjin 301800,China)
关键词:
胰岛素; 唑来膦酸; 糖尿病骨质疏松; 骨代谢; 血脂; 血糖
Keywords:
Insulin; Zoledronic acid; Diabetic osteoporosis; Bone metabolism; Blood lipids; Blood sugar
分类号:
R58；
DOI:
10.3969/j.issn.1006-1959.2019.22.045
文献标志码:
A
摘要:
目的 分析胰岛素联合唑来膦酸治疗对糖尿病骨质疏松（DOP）患者血糖血脂以及骨代谢指标的影响。方法 选择2016年12月~2019年4月于我院诊治的DOP患者共136例进行研究，采用随机数字表法分为对照组和实验组，每组68例，对照组采用二甲双胍联合唑来膦酸治疗，实验组采用胰岛素联合唑来膦酸治疗，比较两组干预后血脂水平（TG、TC、LCL-C、HDL-C）、血糖指标（空腹、餐后2h、糖化血红蛋白）以及骨代谢相关指标（BAP、TRAP-5b、BGP以及s-CTX）。结果 治疗后实验组空腹、餐后2h血糖及HbA1c均低于对照组（P＜0.05）；实验组治疗后TG、TC、LCL-C、HDL-C水平均低于对照组（P＜0.05）；实验组BAP、BGP水平均高于对照组（P＜0.05）；实验组TRAP-5b水平均低于对照组（P＜0.05）；两组s-CTX指标比较，差异无统计学意义（P＞0.05）。结论 对DOP患者使用胰岛素与唑来膦酸联合治疗方案，有助于改善患者的血脂以及血糖水平，同时利于患者骨骼骨质的沉积，值得临床应用。
Abstract:
Objective To analyze the effect of insulin combined with zoledronic acid on blood glucose, blood lipids and bone metabolism in patients with diabetic osteoporosis (DOP). Methods A total of 136 patients with DOP who were treated in our hospital from December 2016 to April 2019 were enrolled in the study. They were randomly divided into the control group and the experimental group, 68 in each group. The control group was treated with metformin and zoledron. Acid treatment, the experimental group was treated with insulin combined with zoledronic acid, blood lipid levels (TG, TC, LCL-C, HDL-C), blood glucose levels (fasting, 2h postprandial, glycated hemoglobin) and bone metabolism were compared between the two groups. Related indicators (BAP, TRAP-5b, BGP, and s-CTX). Results After treatment, the fasting, 2h postprandial blood glucose and HbAlc in the experimental group were lower than the control group(P<0.05). The TG, TC, LCL-C and HDL-C levels in the experimental group were lower than those in the control group(P<0.05); the BAP and BGP levels in the experimental group were higher than those in the control group(P<0.05); the TRAP-5b level in the experimental group was lower than that in the control group(P<0.05); the difference of s-CTX between the two groups, the difference was not statistically significant (P>0.05). Conclusion The combination of insulin and zoledronic acid in patients with DOP can improve the blood lipid and blood glucose levels of patients, and it is beneficial to the deposition of skeletal bone. It is worthy of clinical application.

参考文献/References:

[1]林玺,许旭昀,陈子睿.统计分析糖尿病性骨质疏松症的病机及用药规律[J].新中医,2016,48(7):261-263. [2]王芳,任汉强,沈晓波.胰岛素联合阿仑磷酸钠对老年糖尿病骨质疏松症患者骨密度及血清BAP、TRAP-5b、BGP水平影响[J].海南医学院学,2016,22(13):1387-1389. [3]叶任高.内科学[M].北京:人民卫生出版社,2000:810-887. [4]黄渭军.扶正化瘀法治疗老年骨质疏松症患者75例[J].中国中医药科技,2015,22(2):216-217. [5]卢燕,王晶璞,刘莉红.胰岛素联合唑来磷酸治疗老年糖尿病合并骨质疏松病人的疗效研究[J].实用老年医学,2019,33(6):565-568. [6]赵伟平.唑来磷酸联合胰岛素治疗老年糖尿病骨质疏松症患者的临床疗效及其对骨相关代谢指标的影响[J].中国慢性病预防与控制,2017,25(6):457-459.

相似文献/References:

[1]张熠霖,皇晓燕,赵滢滢,等.糖尿病胰岛病变及胰岛β细胞胰岛素分泌损伤检测的整合实验相关经验探讨[J].医学信息,2019,32(01):18.[doi:10.3969/j.issn.1006-1959.2019.01.006]
　ZHANG Yi-lin,HUANG Xiao-yan,ZHAO Ying-ying,et al.Experience in the Integration Experiment of Diabetic Islet Lesions and Islet β-cell Insulin Secretion Damage Detection[J].Journal of Medical Information,2019,32(22):18.[doi:10.3969/j.issn.1006-1959.2019.01.006]
[2]蔡 玲.不同胰岛素给药模式对高龄妊娠期糖尿病患者血糖控制及母婴结局的影响[J].医学信息,2020,33(04):141.[doi:10.3969/j.issn.1006-1959.2020.04.045]
　CAI Ling.Effects of Different Insulin Administration Modes on Blood Glucose Control andMaternal and nfant Outcomes in Elderly Gestational Diabetes Mellitus Patients[J].Journal of Medical Information,2020,33(22):141.[doi:10.3969/j.issn.1006-1959.2020.04.045]
[3]李 博.唑来膦酸联合放疗治疗恶性肿瘤骨转移患者的效果[J].医学信息,2020,33(09):138.[doi:10.3969/j.issn.1006-1959.2020.09.044]
　YU Shou-jie,JIA Qian.The Effect of Zoledronic Acid Combined with Radiotherapy in Patients with Bone Metastases from Malignant TumorsLI Bo[J].Journal of Medical Information,2020,33(22):138.[doi:10.3969/j.issn.1006-1959.2020.09.044]
[4]王 伟,刘 英.促胰岛素分泌抗糖尿病药物及其作用机制[J].医学信息,2020,33(11):30.[doi:10.3969/j.issn.1006-1959.2020.11.011]
　WANG Wei,LIU Ying.Insulin-promoting Anti-diabetic Drugs and Its Mechanism of Action[J].Journal of Medical Information,2020,33(22):30.[doi:10.3969/j.issn.1006-1959.2020.11.011]
[5]李垄英,王启平,黄 慧.唑来膦酸、化疗联合多维度协同管理治疗非小细胞肺癌骨转移的疗效及对患者疼痛程度和生活质量的影响[J].医学信息,2022,35(21):98.[doi:10.3969/j.issn.1006-1959.2022.21.023]
　LI Long-ying,WANG Qi-ping,HUANG Hui.Efficacy of Zoledronic Acid and Chemotherapy Combined with Multidimensional Collaborative Management in the Treatment of Bone Metastasis of Non-small Cell Lung Cancer and its Effect on Pain Degree and Quality of Life[J].Journal of Medical Information,2022,35(22):98.[doi:10.3969/j.issn.1006-1959.2022.21.023]
[6]高艳红,哈海枫,陈小军,等.甘精胰岛素联合瑞格列奈治疗老年2型糖尿病的临床效果[J].医学信息,2021,34(01):152.[doi:10.3969/j.issn.1006-1959.2021.01.041]
　GAO Yan-hong,HA Hai-feng,CHEN Xiao-jun,et al.Clinical Effect of Insulin Glargine Combined with Repaglinide in the Treatment of Elderly Type 2 Diabetes[J].Journal of Medical Information,2021,34(22):152.[doi:10.3969/j.issn.1006-1959.2021.01.041]
[7]李 亚,宋大庆,韩翔宇,等.胰岛素强化降糖治疗对AMI伴高血糖患者心室重构及血清炎性因子影响的Meta分析[J].医学信息,2021,34(07):110.[doi:10.3969/j.issn.1006-1959.2021.07.030]
　LI Ya,SONG Da-qing,HAN Xiang-yu,et al.Meta-analysis of the Effect of Insulin Intensive Hypoglycemic Therapy on Ventricular Remodeling and Serum Inflammatory Factors in Patients with AMI with Hyperglycemia[J].Journal of Medical Information,2021,34(22):110.[doi:10.3969/j.issn.1006-1959.2021.07.030]
[8]黄应钟,杨立进.序贯抗骨质疏松对老年股骨粗隆间骨折愈合时间及再骨折的影响[J].医学信息,2021,34(18):94.[doi:10.3969/j.issn.1006-1959.2021.18.024]
　HUANG Ying-zhong,YANG Li-jin.The Effect of Sequential Anti-osteoporosis on the Healing Time ofIntertrochanteric Fracture and Re-fracture in the Elderly[J].Journal of Medical Information,2021,34(22):94.[doi:10.3969/j.issn.1006-1959.2021.18.024]
[9]陶 蕾,张宏江,范中阳.利拉鲁肽联合胰岛素治疗肥胖2型糖尿病的疗效[J].医学信息,2021,34(23):99.[doi:10.3969/j.issn.1006-1959.2021.23.028]
　TAO Lei,ZHANG Hong-jiang,FAN Zhong-yang.Effect of Liraglutide Combined with Insulin in the Treatment of Obesity Type 2 Diabetes Mellitus[J].Journal of Medical Information,2021,34(22):99.[doi:10.3969/j.issn.1006-1959.2021.23.028]
[10]朱道信,罗志环,陈少健,等.唑来膦酸联合骨化三醇对骨质疏松症患者骨密度及骨代谢相关指标的影响[J].医学信息,2021,34(23):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]
　ZHU Dao-xin,LUO Zhi-huan,CHEN Shao-jian,et al.Effect of Zoledronic Acid Combined with Calcitriol on Bone Mineral Density and Bone Metabolism in Patients with Osteoporosis[J].Journal of Medical Information,2021,34(22):162.[doi:10.3969/j.issn.1006-1959.2021.23.049]

更新日期/Last Update: 2019-11-15